, January 28, 2026
Regulation of extracellular vesicles for protein secretion in <i>Aspergillus nidulans</i>

Regulation of extracellular vesicles for protein secretion in Aspergillus nidulans

Rebekkah E. Pope1, Patrick Ballmann2, Lisa Whitworth3 and Rolf A. Prade1,*

This study reveals that Aspergillus nidulans boosts extracellular vesicle production when ER-trafficked enzymes are induced, uncovering how fungi remodel their secretome through vesicle-mediated secretion to adapt to changing environments and biofilm formation.

January 23, 2026
Transcriptomic response to different heme sources in <i>Trypanosoma cruzi</i> epimastigotes

Transcriptomic response to different heme sources in Trypanosoma cruzi epimastigotes

Evelyn Tevere1,a, María G. Mediavilla1,a, Cecilia B. Di Capua1, Marcelo L. Merli1, Carlos Robello2,3, Luisa Berná2,4 and Julia A. Cricco

This study uncovers how the Chagas disease parasite adapts to changes in heme, an essential molecule for its survival, providing transcriptional clues to heme metabolism and identifying a previously unreported heme-binding protein in T. cruzi.

, January 21, 2026

Sir2 regulates selective autophagy in stationary-phase yeast cells

Ji-In Ryua, Juhye Junga, and Jeong-Yoon Kim

This study establishes Sir2 as a previously unrecognized regulator of selective autophagy during the stationary phase and highlight how cells dynamically control organelle degradation.

August 2, 2015

A single mutation in the 15S rRNA gene confers non sense suppressor activity and interacts with mRF1 the release factor in yeast mitochondria

Ali Gargouri, Catherine Macadré and Jaga Lazowska

This article presents the nucleotide sequence of the mim3-1 mitochondrial ribosomal suppressor, acting on ochre mitochondrial mutations and one frameshift mutation in Saccharomyces cerevisiae. A hypothetical mechanism of suppression by “ribosome shifting” is also discussed in view of the nature of mutations suppressed and not suppressed.

July 30, 2015

The lysosomotropic drug LeuLeu-OMe induces lysosome disruption and autophagy-independent cell death in Trypanosoma brucei

Hazel Xinyu Koh1,2, Htay Mon Aye1, Kevin S. W. Tan2 and Cynthia Y. He1

Trypanosoma brucei is a blood-borne, protozoan parasite that causes African sleeping sickness in humans and nagana in animals. The current chemotherapy relies on only a handful of drugs that display undesirable toxicity, poor efficacy and drug-resistance. In this study, we explored the use of lysosomotropic drugs to induce bloodstream form T. brucei cell death via lysosome destabilization. We measured drug concentrations that inhibit cell proliferation by 50% (IC50) for several compounds, chosen based on their lysosomotropic effects previously reported in Plasmodium falciparum. The lysosomal effects and cell death induced by L-leucyl-L-leucyl methyl ester (LeuLeu-OMe) were further analyzed by flow cytometry and immunofluorescence analyses of different lysosomal markers…

July 6, 2015

In Entamoeba histolytica, a BspA family protein is required for chemotaxis toward tumour necrosis factor

Anne Silvestre1, 2, 3, 4, Aurélie Plaze1, 2, Patricia Berthon3, 4, Roman Thibeaux1, 2, Nancy Guillen1, 2 and Elisabeth Labruyère1, 2

Background: Entamoeba histolytica cell migration is essential for the development of human amoebiasis (an infectious disease characterized by tissue invasion and destruction). The tissue inflammation associated with tumour necrosis factor (TNF) secretion by host cells is a well-documented feature of amoebiasis. Tumour necrosis factor is a chemoattractant for E. histolytica, and the parasite may have a TNF receptor at its cell surface. Methods: confocal microscopy, RNA Sequencing, bioinformatics, RNA antisense techniques and histological analysis of human colon explants were used to characterize the interplay between TNF and E. histolytica. Results: an antibody against human TNF receptor 1 (TNFR1) stained the E. histolytica trophozoite…

June 25, 2015

Human Thyroid Cancer-1 (TC-1) is a vertebrate specific oncogenic protein that protects against copper and pro-apoptotic genes in yeast

Natalie K. Jones1,2,4,#, Nagla T.T. Arab1,3,#, Rawan Eid1,3,#, Nada Gharib1,5, Sara Sheibani1,2,6, Hojatollah Vali2, Chamel Khoury1, Alistair Murray1,2, Eric Boucher2, Craig A. Mandato2, Paul G. Young3 and Michael T. Greenwood1

The human Thyroid Cancer-1 (hTC-1) protein, also known as C8orf4 was initially identified as a gene that was up-regulated in human thyroid cancer. This article reports that hTC-1 is a peptide that prevents the effects of over-expressing Bax in yeast. In sum, the results indicate that hTC-1 is a pro-survival protein that retains its function when heterologously expressed in yeast. Thus yeast is a useful model to characterize the potential roles in cell death and survival of cancer related genes.

May 20, 2015

Polyamines directly promote antizyme-mediated degradation of ornithine decarboxylase by the proteasome

R. Roshini Beenukumar1,#, Daniela Gödderz1,2,#, R. Palanimurugan1,3, and R. Jürgen Dohmen1

Ornithine decarboxylase (ODC), a ubiquitin-independent substrate of the proteasome, is a homodimeric protein with a rate-limiting function in polyamine biosynthesis. Polyamines regulate ODC levels by a feedback mechanism mediated by ODC antizyme (OAZ). Higher cellular polyamine levels trigger the synthesis of OAZ and also inhibit its ubiquitin-dependent proteasomal degradation. OAZ binds ODC monomers and targets them to the proteasome. Here, we report that polyamines, aside from their role in the control of OAZ synthesis and stability, directly enhance OAZ-mediated ODC degradation by the proteasome. Using a stable mutant of OAZ, we show that polyamines promote ODC degradation in Saccharomyces cerevisiae cells even when OAZ levels are not changed. Furthermore, polyamines stimulated the in vitro degradation of ODC by the…

May 4, 2015

Toxoplasma gondii inhibits cytochrome c-induced caspase activation in its host cell by interference with holo-apoptosome assembly

Kristin Graumann1,3,#, Frieder Schaumburg1,4,#, Thomas F. Reubold2, Diana Hippe1, Susanne Eschenburg2 and Carsten G. K. Lüder1

Inhibition of programmed cell death pathways of mammalian cells often facilitates the sustained survival of intracellular microorganisms. The apicomplexan parasite Toxoplasma gondii is a master regulator of host cell apoptotic pathways. Here, we have characterized a novel anti-apoptotic activity of T. gondii. Using a cell-free cytosolic extract model, we show that T. gondii interferes with the activities of caspase 9 and caspase 3/7 which have been induced by exogenous cytochrome c and dATP. Proteolytic cleavage of caspases 9 and 3 is also diminished suggesting inhibition of holo-apoptosome function. Parasite infection of Jurkat T cells and subsequent triggering of apoptosome formation by exogenous cytochrome c in vitro and in vivo indicated that…

May 1, 2015

Exogenous folates stimulate growth and budding of Candida glabrata

Afsaneh Porzoor and Ian G. Macreadie

Folate, vitamin B9, is well recognized as being essential for cell growth. The utilization of folate is common to all cells, but the source of it may be quite different. This article reports a novel response of yeast to folates that may increase the utility of yeast as a model to study folate transport and signaling.

April 6, 2015

Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism

Camilla Ceccatelli Berti1, Cristina Dallabona1, Mirca Lazzaretti1, Sabrina Dusi2, Elena Tosi1, Valeria Tiranti2, Paola Goffrini1

Mutations in nuclear genes associated with defective coenzyme A biosynthesis have been identified as responsible for some forms of neurodegeneration with brain iron accumulation (NBIA), namely PKAN and CoPAN. Yeast expressing a pathogenic mutation exhibited a temperature-sensitive growth defect in the absence of pantothenate and a reduced CoA content. Additional characterization revealed decreased oxygen consumption, reduced activities of mitochondrial respiratory complexes, higher iron content, increased sensitivity to oxidative stress and reduced amount of lipid droplets, thus partially recapitulating the phenotypes found in patients and establishing yeast as a potential model to clarify the pathogenesis underlying PKAN and CoPAN diseases.

Previous Next
, January 5, 2014

A novel mechanism involved in the coupling of mitochondrial biogenesis to oxidative phosphorylation

Jelena Ostojić1, Jean-Paul di Rago2,3, Geneviève Dujardin1,*

This article comments on a study by Ostojić et al. (Cell Metabolism, 2013), which has uncovered a regulatory loop by which the biogenesis of a major enzyme of the OXPHOS pathway, the respiratory complex III, is coupled to the energy producing activity of the mitochondria.

, January 4, 2014

Stalling autophagy: a new function for Listeria phospholipases

Ivan Tattoli1,2, Matthew T. Sorbara2, Dana J. Philpott2 and Stephen E. Girardin1,*

This article comments on a study biy Tattoli et al. (EMBO J, 2013), which demonstrated that Listeria PI-PLC and PC-PLC contribute to the bacterial escape from autophagy through a mechanism that involves direct inhibition of the autophagic flux in the infected cells

, January 4, 2014

Identifying the assembly pathway of cyanophage inside the marine bacterium using electron cryo-tomography

Wei Dai1, Michael F. Schmid1, Jonathan A. King2, Wah Chiu1,*

Thiswork comments on a study by Dai et al. (Nature 2013) that illustrates that electron cryo-tomography is an approach whereby one can capture directly structural snapshots of transient phage assembly intermediates during maturation process. Such analysis can be generalizable not only to human viruses in human cells but also various molecular machines undergoing biological processes.

Previous
, February 21, 2025

It takes four to tango: the cooperative adventure of scientific publishing

Didac Carmona-Gutierrez1,2, Katharina Kainz1 and Frank Madeo1-3

This Editorial is the 500th article published in Microbial Cell, a journey that started in 2014 and has seen the journal grow steadily and maintain itself as a respected community platform. The foundation that has allowed for and driven this development – as for any responsible journal – is composed of four essential pillars: the readers, the authors, the editors and the referees.

, August 20, 2024
Patterns of protein synthesis in the budding yeast cell cycle: variable or constant?

Patterns of protein synthesis in the budding yeast cell cycle: variable or constant?

Eun-Gyu No, Heidi M Blank and Michael Polymenis

Proteins are the principal macromolecular constituent of proliferating cells, and protein synthesis is viewed as a primary metric of cell growth. While there are celebrated examples of proteins whose levels are periodic in the cell cycle (e.g., cyclins), the concentration of most proteins was not thought to change in the cell cycle, but some recent results challenge this notion. The ‘bulk’ protein is the focus of this article, specifically the rate of its synthesis, in the budding yeast Saccharomyces cerevisiae.

, June 1, 2023

Ribose 5-phosphate: the key metabolite bridging the metabolisms of nucleotides and amino acids during stringent response in Escherichia coli?

Paulina Katarzyna Grucela1, Tobias Fuhrer2, Uwe Sauer2, Yanjie Chao3 and Yong Everett Zhang1

Here we propose the metabolite ribose 5’-phosphate as the key link between nucleotide and amino acid metabolisms and a working model integrating both the transcriptional and metabolic effects of (p)ppGpp on E. coli physiological adaptation during the stringent response.

August 24, 2022

Flagellated bacterial porter for in situ tumor vaccine

Haiheng Xu1, Yiqiao Hu1, 2 and Jinhui Wu1, 2, 3

Cancer immunotherapy, which use the own immune system to attack tumors, are increasingly popular treatments. But, due to the tumor immunosuppressive microenvironment, the antigen presentation in the tumor is limited. Recently, a growing number of people use bacteria to stimulate the body’s immunity for tumor treatment due to bacteria themselves have a variety of elements that activate Toll-like receptors. Here, we discuss the use of motility of flagellate bacteria to transport antigens to the tumor periphery to activate peritumoral dendritic cells to enhance the effect of in situ tumor vaccines.

August 1, 2022

The rise of Candida auris: from unique traits to co-infection potential

Nadine B. Egger1,§, Katharina Kainz1,§, Adina Schulze1, Maria A. Bauer1, Frank Madeo1-3 and Didac Carmona-Gutierrez1

Candida auris is a multidrug resistant (MDR) fungal pathogen with a crude mortality rate of 30-60%. First identified in 2009, C. auris has been rapidly rising to become a global risk in clinical settings and was declared an urgent health threat by the Centers for Disease Control and Prevention (CDC). A concerted global action is thus needed to successfully tackle the challenges created by this emerging fungal pathogen. In this brief article, we underline the importance of unique virulence traits, including its easy transformation, its persistence outside the host and its resilience against multiple cellular stresses, as well as of environmental factors that have mainly contributed to the rise of this superbug.

April 4, 2022

A hundred spotlights on microbiology: how microorganisms shape our lives

Didac Carmona-Gutierrez1, Katharina Kainz1, Andreas Zimmermann1, Sebastian J. Hofer1, Maria A. Bauer1, Christoph Ruckenstuhl1, Guido Kroemer2-4 and Frank Madeo1,5,6

Viral, bacterial, fungal and protozoal biology is of cardinal importance for the evolutionary history of life, ecology, biotechnology and infectious diseases. Various microbiological model systems have fundamentally contributed to the understanding of molecular and cellular processes, including the cell cycle, cell death, mitochondrial biogenesis, vesicular fusion and autophagy, among many others. Microbial interactions within the environment have profound effects on many fields of biology, from ecological diversity to the highly complex and multifaceted impact of the microbiome on human health. Also, biotechnological innovation and corresponding industrial operations strongly depend on microbial engineering. With this wide range of impact in mind, the peer-reviewed (…)

March 21, 2022

Yeast goes viral: probing SARS-CoV-2 biology using S. cerevisiae

Brandon Ho1, Raphael Loll-Krippleber1 and Grant W. Brown1

The budding yeast Saccharomyces cerevisiae has long been an outstanding platform for understanding the biology of eukaryotic cells. Robust genetics, cell biology, molecular biology, and biochemistry complement deep and detailed genome annotation, a multitude of genome-scale strain collections for functional genomics, and substantial gene conservation with Metazoa to comprise a powerful model for modern biological research. Recently, the yeast model has demonstrated its utility in a perhaps unexpected area, that of eukaryotic virology. Here we discuss three innovative applications of the yeast model system to reveal functions and investigate variants of proteins encoded by the SARS-CoV-2 virus.

, December 6, 2021

Murals meet microbes: at the crossroads of microbiology and cultural heritage

Maria A. Bauer1, Katharina Kainz1, Christoph Ruckenstuhl1, Frank Madeo1-3 and Didac Carmona-Gutierrez1

This article comments on the duality of microorganisms in the conservation and restoration of cultural heritage, which encompasses the negative impact of damaging microorganisms and recent advances in using specific microorganisms and microbial-based technologies for cultural heritage preservation.

, September 21, 2021

Urm1, not quite a ubiquitin-like modifier?

Lars Kaduhr1, Cindy Brachmann1, Keerthiraju Ethiraju Ravichandran2,3, James D. West4, Sebastian Glatt2 and Raffael Schaffrath1

This article comments on work published by Brachmann et al. (Redox Biol, 2020), which studied urmylation of the yeast 2-Cys peroxiredoxin Ahp1, uncovering that promiscuous lysine target sites and specific redox requirements determine the Urm1 acceptor activity of the peroxiredoxin.

Next

Microbial Cell

is an open-access, peer-reviewed journal that publishes exceptionally relevant research works that implement the use of unicellular organisms (and multicellular microorganisms) to understand cellular responses to internal and external stimuli and/or human diseases.

Metrics
you can trust

Can’t find what you’re looking for?

You can browse all our issues and published articles here.

FAQs

Whether you’re preparing a manuscript, reviewing a paper, or just exploring the journal, this FAQ answers the essentials—from scope and founders to impact and how to submit. Prefer a tailored path? Pick For authors or For reviewers below.

Peer-reviewed, open-access research using unicellular organisms (and multicellular microorganisms) to understand cellular responses and human disease.

The journal (founded in 2014) is led by its Editors-in-Chief Frank Madeo, Didac Carmona-Gutierrez, and Guido Kroemer

Microbial Cell has been publishing original scientific literature since 2014, and from the very beginning has been managed by active scientists through an independent Publishing House (Shared science Publishers). The journal was conceived as a platform to acknowledge the importance of unicellular organisms, both as model systems as well as in the biological context of human health and disease.

Ever since, Microbial Cell has very positively developed and strongly grown into a respected journal in the unicellular research community and even beyond. This scientific impact is reflected in the yearly number of citations obtained by articles published in Microbial Cell, as recorded by the Web of Science (Clarivate, formerly Thomson/Reuters):

The scientific impact of Microbial Cell is also mirrored in a series of milestones:

2015: Microbial Cell is included in the Emerging Sources Citation Index (ESCI), a selection of developing journals drafted by Clarivate Analytics based on the candidate’s publishing standards, quality, editorial content, and citation data. Note: As an ESCI-selected journal, Microbial Cell is currently being evaluated in a rigorous and long process to determine an inclusion in the Science Citation Index Expanded (SCIE), which allows the official calculation of Clarivate Analytics’ impact factor.

2016: Microbial Cell is awarded the so-called DOAJ Seal by the selective Directory of Open Access Journals (DOAJ). The DOAJ Seal is an exclusive mark of certification for open access journals granted by DOAJ to journals that adhere to outstanding best practice and achieve an extra high and clear commitment to open access and high publishing standards.

2017: Microbial Cell is included in Pubmed Central (PMC), allowing the archiving of all the journal’s articles in PMC and PubMed.

2019: Microbial Cell is indexed in the prestigious abstract and citation database Scopus after a thorough selection process. This also means that Microbial Cell obtains, for the first time, an official Scopus CiteScore as well as an official journal ranking in the Scimago Journal and Country Ranking.

2022: Microbial Cell’s CiteScore reaches a value of 7.2 for the year 2021, positioning Microbial Cell among the top microbiology journals (previously available CiteScores: 2019: 5.4; 2020: 5.1).

2022: Microbial Cell is indexed in the highly selective Science Citation Index Expanded™, which covers approx. 9,500 of the world’s most impactful journals across 178 scientific disciplines. In their journal selection and curation process, Clarivate´s editors apply 24 ‘quality’ criteria and four ‘impact’ criteria to select the most influential journals in their respective fields. This selection is also a pre-requisite for inclusion in the JCR, which features the impact factor.

2022: Microbial Cell is listed in the Journal Citation Reports™ (JCR), and obtains its first official Journal Impact Factor™ (JIF) for the year 2021: 5.316.

Check Article Types and Manuscript Preparation guidelines. Submit online via Scholastica.